tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

CATX Stock Latest News

Perspective Therapeutics initiated with a Buy at BTIG
The FlyPerspective Therapeutics initiated with a Buy at BTIG
9d ago
CATX
Positive Buy Rating for Perspective Therapeutics Driven by Promising Clinical Progress and Market Potential of FAP-Targeted Therapy
PremiumRatings
Positive Buy Rating for Perspective Therapeutics Driven by Promising Clinical Progress and Market Potential of FAP-Targeted Therapy
16d ago
CATX
Perspective Therapeutics announces first patient treated with PSV359
PremiumThe Fly
Perspective Therapeutics announces first patient treated with PSV359
17d ago
CATX
Perspective Therapeutics Updates Radiopharmaceutical Advancements
PremiumCompany Announcements
Perspective Therapeutics Updates Radiopharmaceutical Advancements
17d ago
8K
CATX
Optimistic Buy Rating for Perspective Therapeutics Driven by Promising Trial Results and Upcoming Catalysts
PremiumRatings
Optimistic Buy Rating for Perspective Therapeutics Driven by Promising Trial Results and Upcoming Catalysts
30d ago
CATX
Perspective Therapeutics: Promising Developments and Strong Buy Rating Amidst Encouraging Clinical Trial Results
PremiumRatingsPerspective Therapeutics: Promising Developments and Strong Buy Rating Amidst Encouraging Clinical Trial Results
1M ago
CATX
Oppenheimer more confident Perspective’s VMT update will build on prior results
Premium
The Fly
Oppenheimer more confident Perspective’s VMT update will build on prior results
1M ago
CATX
Perspective announces first patient dosed in cohort of Phase 1/2a trial
Premium
The Fly
Perspective announces first patient dosed in cohort of Phase 1/2a trial
1M ago
CATX
3 Best Stocks to Buy Now, 9/11/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 9/11/2025, According to Top Analysts
1M ago
CATX
ONON
Perspective Therapeutics Appoints Joel Sendek as CFO
PremiumCompany Announcements
Perspective Therapeutics Appoints Joel Sendek as CFO
1M ago
8K
CATX
Perspective Therapeutics appoints Joel Sendek as CFO
PremiumThe Fly
Perspective Therapeutics appoints Joel Sendek as CFO
1M ago
CATX
Perspective Therapeutics management to meet with Oppenheimer
PremiumThe Fly
Perspective Therapeutics management to meet with Oppenheimer
2M ago
CATX
Perspective Therapeutics Appoints Maya Martinez-Davis to Board
PremiumCompany AnnouncementsPerspective Therapeutics Appoints Maya Martinez-Davis to Board
2M ago
8K
CATX
Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
Premium
The Fly
Perspective Therapeutics appoints Maya Martinez-Davis to board of directors
2M ago
GSK
CATX
Perspective Therapeutics Updates on Radiopharmaceutical Advancements
Premium
Company Announcements
Perspective Therapeutics Updates on Radiopharmaceutical Advancements
2M ago
8K
CATX
Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics
PremiumRatings
Promising Clinical Pipeline and Strategic Investments Justify Buy Rating for Perspective Therapeutics
2M ago
CATX
Perspective Therapeutics Reports Q2 2025 Progress and Financials
PremiumCompany Announcements
Perspective Therapeutics Reports Q2 2025 Progress and Financials
2M ago
CATX
Positive Outlook for Perspective Therapeutics: Buy Rating Driven by Promising Clinical Developments and Strategic Progress
PremiumRatings
Positive Outlook for Perspective Therapeutics: Buy Rating Driven by Promising Clinical Developments and Strategic Progress
2M ago
CATX
Perspective Therapeutics Reports Promising Study Results at ASCO
PremiumCompany Announcements
Perspective Therapeutics Reports Promising Study Results at ASCO
2M ago
8K
CATX
Perspective Therapeutics reports Q2 EPS (29c), consensus (29c)
PremiumThe FlyPerspective Therapeutics reports Q2 EPS (29c), consensus (29c)
2M ago
CATX
CATX Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
CATX Upcoming Earnings Report: What to Expect?
2M ago
CATX
Perspective Therapeutics Updates Radiopharmaceutical Platform Presentation
Premium
Company Announcements
Perspective Therapeutics Updates Radiopharmaceutical Platform Presentation
3M ago
8K
CATX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >